Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V-IMMUNE® for Primary Immunodeficiency (VIP Study)
NCT06954441Phase 3Recruiting
- Sponsor
- On Pharma Importadora, Exportadora e Distribuidora de Medicamentos Ltda
- Start
- Aug 2025
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
A Phase 3 trial of Fresh Frozen Plasma in primary immunodeficiency (PI), agammaglobulinemia, sponsored by On Pharma Importadora, Exportadora e Distribuidora de Medicamentos Ltda. Started Aug 2025; status: recruiting.
02
Drugs
Fresh Frozen Plasma
03
Conditions
primary immunodeficiency (PI)agammaglobulinemia
Beyond the preview
Go deeper on NCT06954441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06954441.